Flossbach Von Storch Se Investment Activity in Q2 2026
Flossbach Von Storch Se, with its portfolio totaling $21.86 billion as of June 30, 2026, saw significant changes this quarter including notable purchases and sales across various sectors.

Flossbach Von Storch Se managed a substantial portfolio valued at approximately $21.86 billion (€19.57 billion) as of June 30, 2026. The investment strategy appears focused on large-cap technology stocks like Alphabet Inc. (GOOGL), Microsoft Corp. (MSFT), and Amazon.com Inc. (AMZN), which together constitute a significant portion of the holdings.
According to insider data from Insiderset, Flossbach Von Storch Se held 96 different positions in its portfolio during this period. The top five holdings by value accounted for about 28.96% of the total portfolio allocation, highlighting a concentrated approach despite diversification across sectors.
The investor demonstrated significant buying activity in Q2 2026, notably increasing exposure to NVIDIA Corp. (NVDA) and adding new positions like Zoetis Inc. (ZTS). The following table summarizes key purchases:
- NVIDIA Corp. - Flossbach Von Storch Se increased its stake by 506.43%, adding a significant new position to the portfolio.
- Flossbach Von Storch Se - Acquired Zoetis Inc., representing approximately 1.37% of the total portfolio value.
- ZOETIS Inc. - Entered a new position with this acquisition, adding to its healthcare sector holdings.
- AMETEK Inc. (AME) - The investor sold shares of AMETEK in Q2 2026.
The investment firm also made notable sales during the quarter. Johnson & Johnson Inc. (JNJ), which was previously a top holding, saw its stake reduced by approximately 48%, leading to an exit from one of its core positions. The following table summarizes key exits:
- JOHNSON & JOHNSON - Flossbach Von Storch Se sold shares, reducing its stake by 48%.
- Flossbach Von Storch Se - Significantly decreased holdings in Salesforce Inc. (CRM), removing it from the top five positions.
- SALESFORCE INC. - The stake was reduced by 52.65%, indicating a major sell-off of this stock.
The portfolio's sector allocation remained dominated by Technology and Financial Services, but there were shifts within these categories as well as additions elsewhere. Healthcare saw increased allocations through new positions in ZOETIS INC. (ZTS) and Biontech ADR (BNTX), while reducing exposure to some other healthcare stocks like Johnson & Johnson (JNJ).
In summary, Flossbach Von Storch Se's Q2 2026 activity involved substantial buying in high-growth technology names like NVIDIA CORP. and adding new healthcare positions. Simultaneously, the firm sold significant portions of its holdings in companies like Salesforce (CRM) and exited other core positions such as Johnson & Johnson (JNJ). For more detailed information on Flossbach Von Storch Se's portfolio or specific stock movements, please refer to Insiderset.